AMLX

Amylyx Pharmaceuticals, Inc.

Contracts

Total Value

Stock Metrics

16.0%

Short % Float

6.8d to cover · Moderate squeeze

1.1%

Inst % Float

10 holders · 2026-06-30

FMR, LLC

Top Holder

14.9% of float

83.5M sh

Public Float

27/100

Dilution Score

Medium

68 mo

Cash Runway

Verified regulatory filings & proprietary analysis.

Dilution Risk

27/100

MEDIUM

Inst: 1.08% · Top: FMR, LLC

Biotech Analytics

Biotech / Pharma

40.44

Squeeze risk: MODERATEBiotech Grade: D

Insider Buying0

Publications100

Dilution Risk27

Clinical Trials67

Short Interest50